Journal of Medicine and Palliative Care

The Journal of Medicine and Palliative Care (JOMPAC) aims to publish issues related to palliative care and all fields of Medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. The target audience of the Journal of Medicine and Palliative Care includes specialists and physicians working in palliative care, all fields of Medicine, and all other health professionals interested in these fields.

Journal of Medicine and Palliative Care (JOMPAC) is an unbiased, independent scientific journal that evaluates articles with peer-review and "double-blind" systems. Journal of Medicine and Palliative Care aims to support scientific development and provides information exchange among the readers with clinical and surgical retrospectives, prospective or experimental research, compilation, case report, editorial comments/discussion, editorial letters, scientific letters, surgical techniques, differential diagnosis, original view, what is your diagnosis? book evaluations, questions/answers, and current issues that determine the agenda in the field of journal.

The Journal of Medicine and Palliative Care (JOMPAC) accepts submissions in just English. The publication language of the journal is only English.

1.1 General Format
Manuscripts should be prepared using Microsoft Word, size A4 with 2.5 cm margins on all sides, 12 pt Times New Roman font, and double line spacing. “System International” (SI) units should be used. Abbreviations should be defined at first mention and used consistently thereafter. Manuscripts written in English should be following the Writing Guide and Grammar.The system enables online submission and evaluation of the manuscript.
Text(s) and table(s) should be prepared in MS Word format, and graphic(s), and picture(s) should preferably be in JPEG format (minimum 300 DPI). Figures, tables, pictures, and graphics should be referenced in the text. Abbreviations should be given in parentheses where the word first appears. Articles should be 50% contiguous, a comma should be used in a period (55.78) in English manuscripts.

1.2 Article Type
Identification of article type is the first step of manuscript submission because article type dictates the guidelines that should be used (see below, Using Guidelines), including formatting and word limits of the manuscript. The main categories of article type are outlined below:

Original Article: Original contributions are manuscripts containing substantial novel research. These articles can include randomized controlled trials, observational (cohort, case-control, or cross-sectional) studies, descriptive studies, diagnostic accuracy studies, systematic reviews, and meta-analyses, nonrandomized behavioral and public health intervention trials, experimental animal trials, or any other clinical or experimental studies. Abstracts should not exceed 400 words and should be structured with the following subheadings: Aims, Methods, Results, and Conclusion. The main text should be structured with the following subheadings: Introduction, Methods, Results, Discussion, Acknowledgments, References, Tables, and Figure Legends. The main text should not exceed 4000 words, excluding the abstract, references, tables, and figure legends. It is recommended not to exceed 30 references. All papers but cell studies require ethical approval.

Brief/Case Reports: Brief reports are short and peer-reviewed articles including small case series, case reports, negative trials, preliminary results, and others that are not to be published as a full-text papers. The main text should be less than 2000 words with a maximum of 10 references and have no more than 3 display items (Tables or figures). It is recommended not to exceed 200 words in the abstract. Abstracts should not be configured, and sub-headings should not contain (Aims, Methods, Results, and Conclusion). In case reports, it should be stated that an "informed consent form" is taken.

Review Article: The review articles are comprehensive analyses of specific topics in medicine, which can also be written by invitation, due to the extensive experience and publications of authors on the review subjects. All review articles will also undergo peer review before acceptance. Review articles must not exceed 4000 words for the main text (excluding references, tables, and figure legends) and 400 words for the abstract. A review article can be signed by no more than 4 authors and can have no more than 80 references. It is recommended not to exceed 200 words in the abstract. Abstracts should not be configured, and sub-headings should not contain (Aims, Methods, Results, and Conclusion).Review articles do not require ethical approval.

Letter to the Editor: Letters about a journal article must not exceed 1000 words (excluding references). An abstract is not required for this type of manuscript. A letter can be signed by no more than 3 authors and can have no more than 5 references and 1 figure or table. Authors might be asked for a reply to the letter. Replies must be submitted through the submission system as well.

Clinical Image: For educational purposes, the journal publishes original, interesting, and high-quality clinical images having a brief explanation (maximum 500 words excluding references but including figure legends) and of educational significance. The figure legend should contain no more than 100 words. It can be signed by no more than 5 authors and can have no more than 5 references and 1 figure or table. Any information that might identify the patient or hospital, including the date, should be removed from the image. An abstract is not required for this type of manuscript. The main text of clinical images should be structured with the following subheadings: Case, and References. All papers require the patient's consent.

Editorial Comment: Editorial comments are brief remarks on an article published in the journal by the reviewer of the article or by a relevant authority. Most comments are invited by the Editor-in-Chief but spontaneous comments are welcome. It must not exceed 1000 words (excluding references). An abstract is not required for this type of manuscript. It can have no more than 15 references and 1 figure or table.

Other: Editorials, editorial comments, book reviews, and reports on publication and research ethics are requested by the Editorial Board.

1.3. Clinical Trials and Reporting Guidelines
The Journal of Medicine and Palliative Careencourages the registration of all clinical trials via ClinicalTrials.gov (www.clinicaltrials.gov) or one of the registries of the WHO’s International Clinical Trials Registry Platform (ICTRP: http://www.who.int/ictrp/network/primary/en/index.html). Especially the phase 3 clinical trials must be registered at or before the time of first patient enrollment. The name of the registry and the registration number together with the information on the funding source should be provided at the end of the abstract.
Authors should also refer to the guidelines below when preparing their manuscript
For further information on the reporting guidelines for health research, authors are suggested to refer to the EQUATOR network website (http://www.equator-network.org/)

2. Preparation and Submission of Manuscript
The entire submission process for a manuscript is completed online through the self-explanatory online submission system through the website.

Please be informed that we will ask you to suggest two potential reviewers during the manuscript submission process.

The submission should be divided into SEPARATE files in the following order:
2.1. Cover Letter
2.2. Title Page
2.3. Main Document (Abstract, Main text, references, tables, and figure legends. Abstract of the manuscript should be also submitted through the submission system)
2.4. Tables
2.5. Figures
2.6. Ethics Committee Approval Form
2.7. Copyright Agreement and Acknowledgement of Authorship Form
2.8. The ICMJE Conflict of Interest formand Data-sharing Statement form
2.9. Creative Commons License Agreement Form

2.1. Cover Letter (As a separate file)
The cover letter should include the article title, the full name of the corresponding author, and type of article (original article, case report, review article, letter to editor etc.). The cover letter should also include a statement declaring the absence or presence of a conflict of interest (please refer to theICMJE Conflict of Interest form page for details). Furthermore, there should be a statement that the manuscript has not already been published, accepted, or under simultaneous review for publication elsewhere. Journal of Medicine and Palliative Care does not accept multiple submissions and duplicate submissions even though the previous one was published in a different language. Please refer to the editorial (ICMJE recommendations (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html) on this subject for more details. For manuscripts that have been presented orally or as a poster, this must be stated on the title page with the date and the place of the presentation. An example of a cover letter can be found on the journal’s webpage.

2.2. Title Page (As a separate file)
Title page should include:
The complete manuscript title (no more than 150 characters)
The running head (no more than 50 characters)
All authors' full names with ORCIDs, affiliations, and e-mail addresses (all authors should meet the ICMJE’s requirements for authorship – see details at “Copyright Transfer and Acknowledgement of Authorship Form”
The name, address, telephone, and email address of the corresponding author
Information about where and when the study has previously been presented.
Acknowledgments: All contributors who do not meet the criteria for authorship (ICMJE: authorship and contributorship) and the statement of conflict of interest and funding should be declared under this subheading.
An example of a title page can be found on the journal’s webpage.

2.3. Main Document (As a separate file)
The main document should include the abstract, main text, reference list, tables, and figure legends, respectively.

2.3.a. Abstracts
Original articles, invited review articles, and brief/case reports should include an abstract. Abstracts for original articles should be structured with the following subheadings: Aims, Methods, Results, and Conclusion. Abstracts for review articles and brief/case reports should not be structured. Clinical images, Editorials, Letters to the Editor, and Commentaries should not contain an abstract. Please find the guidelines for abstracts of specific types of manuscripts under the Main Text section below.
Aim: The aim of the study should be clearly stated.
Methods: The study should be described, including selection criteria, design (randomized, retrospective/prospective, etc.), and statistical methods applied, if applicable.
Results: The main results of the study should be stated and the statistical significance level should be indicated.
Conclusion: The results of the study should be summarized and the clinical applicability of the results should be defined.
Keywords: The abstract should be followed by 3 to 6 keywords provided in Index Medicus under “Medical Subject Heading (MeSH)”.

2.3.b. Main Text
a) Original Articles
The main text of the article should include the following headings:
Introduction: This should consist of a brief background to the subject and the study objective(s), supported by information from the literature.
Methods: The study plan should be clearly described, including whether the study was randomized and retrospective or prospective, the inclusion and exclusion criteria applied, the patient/sample number and characteristics, and the statistical methods used.
Results: The results of the study should be stated, with tables/figures given in numerical order; the results should be evaluated according to the statistical analysis methods applied. See the Tables, Graphics, Figures, And Images section of the General Guidelines for details about the preparation of visual material.
Discussion: The study results should be discussed in terms of their favorable and unfavorable aspects and they should be compared with the literature. The conclusion of the study should be highlighted.
Study Limitations: This section should state which data and analyses could not be included in the study, discuss the limitations of the study, and give recommendations for future studies.
Conclusion: Highlights the results obtained and conclusions that can be drawn from the study.
Acknowledgments: Any technical or financial support or editorial contributions (statistical analysis, English evaluation) towards the study should appear at the end of the article.
References: Authors are responsible for the accuracy of the references. See the General Guidelines for details about the usage and formatting required.

b) Brief/Case Reports
Brief/Case reports should present cases that are rarely seen, feature novelty in diagnosis and treatment, and contribute to our current knowledge. The main text should include the introduction, case presentation, discussion, and references.

c)Review Articles
Review articles can address any aspect of clinical or basic topic and should be written in a format that describes, discusses, and analyzes the current state of knowledge or clinical use based on the latest evidence and offers directions for future research. Most review articles are invited, but uninvited review submissions are also welcome. Contacting the section editor is recommended before submitting a review. Reviews articles analyze topics in depth, independently, and without bias. All cited literature should be referenced.

d) Letters to the Editor
Letters to the Editor should be short commentaries related to current developments in the topic and their scientific and social aspects or may ask questions or offer further contributions in response to articles published in the Journal. Any information that may indicate an individual or institution should be excluded from the main document to ensure a blinded review process.

2.3.c. References
Reference listings must be following ICMJE standards and be numbered consecutively at the end of the manuscript in the order in which they are mentioned in the text. Authors are responsible for the accuracy of references. Journal titles should be abbreviated following the journal abbreviations in Index Medicus/ Medline/PubMed (for journal abbreviations consult the List of Journals indexed for MEDLINE, published annually by NLM).
Authors are responsible for the accuracy of the references. References should be numbered consecutively in the order in which they are first mentioned in the text. The Journal of Medicine and Palliative Care uses American Medical Association (AMA) Citation Style for references. Each reference should be cited in the text using superscript Arabic numerals (e.g.,1, 2, 3…). Multiple references may be cited in the same instance. If you are citing sequential references, these should be indicated with a hyphen. Nonsequential references should be separated with commas. There should not be a space between numbers. References are found at the end of a manuscript and are titled “References” and each item should be listed in numerical order as opposed to alphabetically. The format for author names is "Surname1 AB, Surname2 CD, ...". Note that there is a comma between each full name, but there is no punctuation within each name. If a reference has up to six authors, include them all. If there are more than six authors, list the first three, followed by "et al." Then add the name of the article (only the first letter of the sentence and the first letter of the special names will be capitalized), short journal name, year, volume, number, page number (15-8, not 15-18) and a space between the punctuation marks. The name of the journal should be written in italic, and a point should be placed at the end. The format used for the manuscript submission should be as specified in Index Medicus (www.icmje.org).

Examples of references are as follows:
1) Journal article
Author(s), Article title, Journal name (abbreviated and italicized), Year of publication (followed by a semi-colon), Volume number, Issue number, Part or supplement number (when applicable), Inclusive page number(s).The doi number does not need to be added.
Examples:
-Freund KB, Staurenghi G, Jung JJ, et al. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.Graefes Arch Clin Exp Ophthalmol. 2022;260(8):2437-2447.
-Freund KB, Fine HF. Pachychoroid Disease.Ophthalmic Surg Lasers Imaging Retina. 2020;51(4):206-209.
2) Whole Book
Author(s). Book Title. Edition number (if it is the second edition or above). Publisher's name; copyright year.
Example: Riegelman RK, Kirkwood B. Public Health 101: Healthy People--Healthy Populations. 2nd ed. Jones & Bartlett Learning; 2015.
3) Chapter in a Book
Author(s). Chapter title. Editor, eds. In: Author, Book Title. edition. Publisher; Year: pages.
Example: Bliss CM, Wolfe M. Chapter 34: Common clinical manifestations of gastrointestinal disease. In: Andreoli TE, Cecil RL, eds. Andreoli and Carpenter's Cecil Essentials of Medicine. 8th ed. Saunders/Elsevier; 2010:382-400.
4) Article in electronic format
When citing electronic material, in addition to the basic information, you must also, in general,include the DOI. If the DOI is not available, include the URL (link) to the item as well as the date you accessed it. Two tips to keep in mind: provide the most direct urlpossible and if a DOI is listed instead of a URL, it is not necessary to include the date accessed. DOI is preferred over URL.
Examples
Online journal article with volume and page information
Allison MA, Hurley LP, Markowitz L, et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016;137(2):e20152488. doi:10.1542/peds.2015-2488
Online journal article available online before print publication
Tamburini S, Shen N, Chih Wu H, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. Published online July 7, 2016. doi:10.1038/nm4142
Web site
King MW. Carbohydrate Nomenclature. The Medical Biochemistry Page. Updated April 2, 2020. Accessed June 3, 2020. http://themedicalbiochemistrypage.org.
Online book
Gilmore K, Meersand P. Normal Child and Adolescent Development: A Psychodynamic Primer. American Psychiatric Association Publishing; 2014. Accessed August 12, 2019. https://www.r2library.com/Resource/Title/1585624365
Chapter from an online book
Creating safety systems in health care organizations. In: Kohn, LT, Corrigan, JM, and Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington, DC: Committee on Quality of Health Care in America, Institute of Medicine; 2000: chap 8. Accessed November 1, 2016. http://www.nap.edu/openbook.ptp?record_id=9728&page=155
Online reference
Amoxicillin. Micromedex. Truven Health Analytics; 2020. Updated June 2, 2020. Accessed July 22, 2020.http://www.micromedexsolutions.com/micromedex2/librarian#
Preprints
Bloss CS, Wineinger NE, Peters M, et al. A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensors. bioRxiv. Preprint posted online October 28, 2015. doi:10.1101/029983
For other reference styles, please refer to “ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Sample References”

2.3.d- Figure Legends

Legends for illustrations should be written starting on a separate page after references in the main text and Arabic numerals should be used for corresponding illustrations.

2.4. Tables(As a separate file)

Tables should be presented within the main document after the reference list. All tables should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title should be provided for all tables and the titles should be placed above the tables. Abbreviations used in the tables should be defined below the tables (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide an easy reading. Tables, in particular, should be explanatory and facilitate readers’ understanding of the manuscript, and should not repeat data presented in the main text.

2.5. Figures (As a separate file)

Figures, graphics, and photographs should be submitted as separate files (in JPEG format) through the submission system. They should not be embedded in a Word document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures too should be blind. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100 mm)

2.6. Ethics Committee Approval form(As a separate file)

ULAKBIM TR Index made some new regulations to the criteria of 2020 regarding ethical rules. These regulations are summarized below. Please submit your manuscript according to these rules. Authors should obtain the relevant documents and upload them to the system together with their ethical committee approval.
1. "Ethics Committee Approval" is required for all kinds of research conducted with qualitative or quantitative approaches that require data collection from participants using survey, interview, focus group work, observation, experiment, and interview techniques.
2. The articles should state whether an ethical committee permit and/or legal/special permission is required. If these approvals are required, they should be presented from which institution, on what date, and with which decision or number.
3. "Ethics Committee Approval" is required for research using humans and animals (including materials/data) for experimental or other scientific purposes.
4. If the study involves the use of human or animal subjects, the international declaration of the study, guidance, etc. must be declared that it is performed properly.
5. "Ethics Committee Approval" is required for clinical studies on humans and animals.
6. By the law on the protection of personal data, "Ethics Committee Approval" is needed for retrospective studies.
* Retrospective ethics committee approval is not required for articles that were produced from postgraduate/doctoral studies using research data before 2020 (must be specified in the article) and were accepted for publication in the previous year, but have not yet been published.
** In studies that require ethics committee approval, ethics committee approval will be shared with the journal editor. In addition, the name of the committee, the date, and the issue number will be stated in the method section of the article and the ethics committee approval section on the last page of the article.
*** Researchers who are not members of the university can also apply to the Ethics Committees in their region.

2.7. Copyright Agreement and Acknowledgement of Authorship Form

This is a statement of the scientific contributions and responsibilities of all authors. The form is available for download on the journal’s webpage.
The ICMJE recommends that authorship be based on the following 4 criteria:
♦ Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
♦ Drafting the work or revising it critically for important intellectual content; AND
♦ Final approval of the version to be published; AND
♦ Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.”
A contributor should meet all four criteria to be identified as an author. If a contributor does not meet all four criteria, he/she should be acknowledged in the acknowledgments section of the manuscript.
For more details please refer to the ICMJE’s definition of the role of authors and contributors at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

2.8. The ICMJE Conflict of Interest form and Data - sharing Statement form

During submission, the ICMJE Conflict of Interest form should be filled out, saved to your computer, and submitted to the Journal together with your manuscript. Please refer to “conflict of interest policy” for more information. Journal of Medicine and Palliative Care requires authors to submit a Data-sharing Statement form forclinical trialsand register a data-sharing plan when registering a clinical trial on or after Jan 1, 2019. Please refer to the “data-sharing policy” for more information.

2.9. Creative Commons License Agreement Form

After the acceptance of the articles, the corresponding author may be asked to sign the Creative Commons License Agreement form and send it to the publisher. Please refer to the “open access policy” for more information.

Note: ORCID information is being used in national and international journals. ORCID is an organization that provides the Open Researcher and Contributor ID (ORCID), allowing researchers to register for a unique identifier. ORCID is providing an identifier for individuals to use with their names as they engage in research, scholarship, and innovation activities. These identifiers are primarily used to disambiguate authors in the publishing world. The Journal of Medicine and Palliative Care also includes this information for the indexing requirement. You can get your ORCID ID from the link below.

https://orcid.org/register

Journal of Medicine and Palliative Care is a peer-reviewed, open-access journal, which is published 6 issues (February, April, June, August, October, December) per year periodically and is indexed in international indexes. The journal's expenses have been covered by its own resources and donations so far. Due to the increasing publication costs with the increase in the number of articles, the article processing fee will be requested from the authors regardless of rejection or acceptancewho submit articles in order to evaluate the articles as soon as possible, and to provide better consultancy and editing services, this article submission fee, which is not subject to the condition of acceptance or rejection, is requested after the compliance of the article to the journal scope is checked.

Manuscript submission/evaluation fee: Article submission payment for original articles are 180 USD (US Dollars) or 3000 TL (Turkish Liras), and also review and case report articles submission payment 90 USD (US Dollars) or 1500 TL (Turkish Liras).

Fast-track process: All following processes; evaluation for editorial pre-review, prerequisites check, blind review at least by two reviewers, editorial decision will be concluded within 30 working days (working days: monday to friday) (If there is a third referee evaluation process, the process may take longer).

Fast-track process for original articles are 5000 TL (Turkish Liras) or 300 USD (US Dollars), and also review and case report articles submission payment 2500 TL (Turkish Liras) or 150 USD (US Dollars).

After 1 July 2023;

Manuscript submission/evaluation fee: Article submission payment for original articles are 250 USD (US Dollars) or 5000 TL (Turkish Liras), and also review and case report articles submission payment 125 USD (US Dollars) or 2500 TL (Turkish Liras).

Fast-track process: All following processes; evaluation for editorial pre-review, prerequisites check, blind review at least by two reviewers, editorial decision will be concluded within 30 working days (working days: monday to friday) (If there is a third referee evaluation process, the process may take longer).

Fast-track process for original articles are 8000 TL (Turkish Liras) or 400 USD (US Dollars), and also review and case report articles submission payment 4000 TL (Turkish Liras) or 200 USD (US Dollars).

No fee will be taken for short communication, invited review, technical report, and letter to the editor articles

Being a fast-track does not increase the chance of article acceptance. If the article is rejected as a result of the referee evaluation, the fee is not refunded.

Where are the revenues used: Invoices are issued for the fees deposited in our journal and taxes are given. These revenues are used to improve the journals. Professional secretariat, typesetting, design, layout, English language support services are provided. In addition, revenues are used to apply for indexes.

Contact to: mha@medihealthacademy.com

Eligibility of Submission - Submission Fee or Rejection(Please pay after reading the text below)

After your article submission process is over;

It will be evaluated whether your article complies with the journal's writing rules and whether it is at minimum proficiency in terms of content.

• If the article is appropriate; you will be notified by e-mail that your position is available and you will be directed to pay the article submission fee,

• If the article is not appropriate; Rejection letter will be sent by e-mail without requesting submission fee.

Author Information About the Predatory (Looting/Shabby) Journal

A. https://www.uak.gov.tr/Documents/docentlik/2023/2023-mart-donemi/2023M_SikcaSorulanSorularveCevaplari_24022023.pdf

45. Question: Which journals cannot be used in the Associate Professorship Application Requirements (Declaration)?

Answer: The decision numbered 2021.18.643 about Predatory (Looting/Shabby) journals taken at the session of the General Assembly of Higher Education dated December 30, 2021 and numbered 2021.18 is as follows.

* Journals that are not considered Predatory (Looting/Shabby):

o Journals classified as Q1, Q2, Q3 in WEB of Science (with or without charge for editorial and/or printing processes),

o Journals in the Q4 class on WEB of Science that do not charge for editorial processing charge and/or article processing charge,

o National/international journals that are included in the Q4 class on the WEB of Science and charge a fee for editorial and/or printing processes, but are the publication organ of a branch association, university, institute or scientific institution, where only members of the relevant science field can become members, and have been published/published since before 2010 and work as subscribers,

* Predatory (Looting/Shabby) journals: Q4 journals that do not meet the above criteria

According to the decision of the General Assembly of Higher Education dated December 30, 2021, above, articles published in Predatory (Looting/Shabby) journals, the characteristics of which are specified, are added to the list of resumes and works regardless of the date of publication, but cannot be used in the declaration.

C. http://portal.dpu.edu.tr/orhan.elmaci/makale_oku/165/yagmaci-dergi-beall-predatory-listesi-ve-tubitak-turkiye-adresli-uluslararasi-bilimsel-yayinlari-tesvik-ubyt-programi-dergi-listesi

D. https://beallslist.net/